Status:
UNKNOWN
The Approach and Avoidance Task (AAT) in Alcoholic Inpatients
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Alcohol Dependence
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The approach and avoidance task (AAT) has evolved as a promising treatment add-on in the realm of psychology. Certain psychiatric diseases, such as behavioural addictions, social anxiety disorder, and...
Detailed Description
The approach and avoidance task (AAT) has turned out as both a promising diagnostic tool as well as treatment add-on in psychological science. The AAT constitutes one form of cognitive bias modificati...
Eligibility Criteria
Inclusion
- Diagnosis of alcohol dependence (SKID-I)
- Abstinence from alcohol (at least 72 hours) and absence of major withdrawal symptoms
- Being in between 18-76 years of age
- Being able to understand rationales of the study and signing written informed consent
- Currently being inpatient seeking help overcoming alcohol dependence
- Medication allowed: Antiepileptic's (such as Carbamezepin), antidepressants, substances to treat other non-psychiatric diseases
Exclusion
- Impaired ability to cooperate
- Presence of another substance dependency than alcohol and nicotine within the last year
- Presence of another axis-I disorder that interferes with the ability to cooperate within the study programme
- Current episode of a major depression
- Presence of axis-II disorders
- Presence of schizoaffective disorders
- Alcohol consumption in between withdrawal and start of the study
- Somatic or neurological disease that precludes the proper execution of the study
- Long-term intake of neuroleptics or hypnotics
- Current intake of benzodiazepines or Clomethiazol (in the period of five half-value times prior to the start of the study)
- Participation in other studies or other treatments than treatment as usual
- Planned long-term therapy after 3-week withdrawal programme
- Being homeless
- Prior electroconvulsive therapy
- Language barriers that preclude proper understanding of study contents
Key Trial Info
Start Date :
February 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04054336
Start Date
February 2 2017
End Date
August 31 2020
Last Update
August 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Hamburg-Eppendorf
Hamburg, Germany, 20246